Layer, Chiang, et al. Genome Biology
Genesis Receives Funding Commitment for New Subsidiary, Prepares New Share-Purchase Plan
Genesis said that it has received a commitment from an undisclosed group for an investment in the subsidiary, which would develop its single-stranded RNAi technology. But with about two months worth of cash in the bank, the company is asking shareholders to make new equity investments.
New to GenomeWeb? Register here quickly.